TipRanks
Go Ultimate55% OFF

Dermapharm Holding SE (0A5J) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0A5J Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to Dermapharm Holding SE in the past 3 months

0A5J Stock 12 Month Forecast

EUR 52.00▲(34.37% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Dermapharm Holding SE in the last 3 months. The average price target is EUR 52.00 with a high forecast of EUR 60.00 and a low forecast of EUR 44.00. The average price target represents a 34.37% change from the last price of EUR 38.70.
Highest Price TargetEUR 60.00Average Price TargetEUR 52.00Lowest Price TargetEUR 44.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0A5J
Price TargetFollowArticle
JefferiesEUR 44hold13.70%UpsideReiterated09/01/26
Berenberg BankEUR 60buy55.04%UpsideReiterated08/27/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dermapharm Holding SE

3 Months
Gerhard Orgonas
Gerhard OrgonasBerenberg Bank
Success Rate8/14 ratings generated profit
57%
Average Return
+1.75%

Copying Gerhard Orgonas's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +1.75% per trade.

1 Year
Gerhard Orgonas
Gerhard OrgonasBerenberg Bank
Success Rate5/14 ratings generated profit
36%
Average Return
+0.76%

Copying Gerhard Orgonas's trades and holding each position for 1 Year would result in 35.71% of your transactions generating a profit, with an average return of +0.76% per trade.

2 Years
Gerhard Orgonas
Gerhard OrgonasBerenberg Bank
Success Rate7/14 ratings generated profit
50%
Average Return
+3.64%

Copying Gerhard Orgonas's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +3.64% per trade.

0A5J Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 0A5J
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy11110
Hold23441
Sell00000
Strong Sell00000
total34551

In the current month, 0A5J has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 0A5J average Analyst price target in the past 3 months is 52.00.

0A5J Financial Forecast

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q4 2025Q2 2026Q3 2026
ConsensusEUR 0.47

0A5J Earnings Forecast

Next quarter’s earnings estimate for 0A5J is EUR 0.47 with a range of ― to ―. The previous quarter’s EPS was EUR 0.47. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 285.2MEUR 290.3MEUR 295.5MEUR 300.6MEUR 305.8MQ4 2025Q2 2026Q3 2026
ConsensusEUR 285M

0A5J Sales Forecast

Next quarter’s sales forecast for 0A5J is EUR 285.15M with a range of ― to ―. The previous quarter’s sales results were EUR 285.15M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0A5J Stock Forecast FAQ

What is GB:0A5J’s average 12-month price target, according to analysts?
Based on analyst ratings, Dermapharm Holding SE’s 12-month average price target is €52.00.
What is GB:0A5J’s upside potential, based on the analysts’ average price target?
Dermapharm Holding SE has 34.37% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dermapharm Holding SE a Buy, Sell or Hold?
Dermapharm Holding SE has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Dermapharm Holding SE’s share price target?
The average share price target for Dermapharm Holding SE is €52.00. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €60.00, and the lowest forecast is €44.00. The average share price target represents a 34.37% increase from the current price of €38.7.
What do analysts say about Dermapharm Holding SE?
Dermapharm Holding SE’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Dermapharm Holding SE?
To buy shares of GB:0A5J, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.